Data Manipulation Not Common, But Happens "More Than I Would Have Expected," US FDA's Sharpless Says

 
• By Michael Cipriano
  
FDA acting Commissioner Ned Sharpless speaking at FDLI 2019
Norman Sharpless broadly addressed the frequency of data manipulation at the US FDA.

More from Legal & IP

More from Pink Sheet